Actionable news
All posts from Actionable news
Actionable news in BLUE: bluebird bio, Inc.,

Bluebird Bio (BLUE) Showing Signs Of A Dead Cat Bounce Today

Trade-Ideas LLC identified bluebird bio ( BLUE) as a "dead cat bounce" (down big yesterday but up big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified bluebird bio as such a stock due to the following factors:

  • BLUE has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $32.4 million.
  • BLUE has traded 58,048 shares today.
  • BLUE is up 3.5% today.
  • BLUE was down 6.3% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in BLUE with the Ticky from Trade-Ideas. See the FREE profile for BLUE NOW at Trade-Ideas More details on BLUE: bluebird bio, Inc., a clinical-stage biotechnology company, focuses on developing transformative gene therapies for severe genetic and rare diseases. Currently there are 9 analysts that rate bluebird bio a buy, no analysts rate it a sell, and 2 rate it a hold. The average volume for bluebird bio has been 1.2 million shares per day over the past 30 days. Bluebird bio has a market cap of $1.4 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.78 and a short float of 29.1% with 7.71 days to cover. Shares are down 43.6% year-to-date as of the close of...